Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 CAD | -5.26% | -2.70% | -14.29% |
Feb. 14 | Helix BioPharma Corp. Appoints Praveen Varshney as Corporate Secretary | CI |
Feb. 14 | Helix BioPharma Corp. Appoints Praveen Varshney as Chief Financial Officer | CI |
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jacek Antas
CEO | Chief Executive Officer | - | 22-04-17 |
Director of Finance/CFO | 59 | Feb. 13 | |
Chief Tech/Sci/R&D Officer | - | 22-08-31 | |
Chief Tech/Sci/R&D Officer | - | 19-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 22-04-17 | |
Jacek Antas
CEO | Chief Executive Officer | - | 22-04-17 |
Malgorzata Laube
BRD | Director/Board Member | - | 22-12-07 |
Janusz Grabski
BRD | Director/Board Member | - | 23-08-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 216,674,415 | 169,754,541 ( 78.35 %) | 0 | 78.35 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.29% | 28.79M | |
+9.72% | 46.21B | |
+35.14% | 40.04B | |
+4.84% | 39.92B | |
-9.43% | 28.33B | |
+17.47% | 27.43B | |
-22.99% | 18.57B | |
+10.88% | 13.46B | |
+27.53% | 12.02B | |
-6.84% | 11.3B |
- Stock
- Equities
- Stock Helix BioPharma Corp. - Toronto S.E.
- Company Helix BioPharma Corp.